KPTI, PRSO and NERV among mid-day movers

seekingalpha02-06

Gainers: Yield10 Bioscience (YTEN) +77%. 4D Molecular Therapeutics (FDMT) +74%. Chenghe Acquisition Co (CHEA) +58%. Morphosys (MOR) +45%. Rail Vision Ltd (RVSN) +34%. Adverum Biotechnologies (ADVM) +...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2409455376?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","is_english":true,"pubTime":"2024-02-06 02:05","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2409455376","market":"us","top_or_hot":-1,"title":"KPTI, PRSO and NERV among mid-day movers","media":"seekingalpha","content":"<div>\n<p>Gainers: Yield10 Bioscience (YTEN) +77%. 4D Molecular Therapeutics (FDMT) +74%. Chenghe Acquisition Co (CHEA) +58%. Morphosys (MOR) +45%. Rail Vision Ltd (RVSN) +34%. Adverum Biotechnologies (ADVM) +...</p>\n\n<a href=\"https://seekingalpha.com/news/4062759-kpti-prso-and-nerv-among-mid-day-movers\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KPTI, PRSO and NERV among mid-day movers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKPTI, PRSO and NERV among mid-day movers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-06 02:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4062759-kpti-prso-and-nerv-among-mid-day-movers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers: Yield10 Bioscience (YTEN) +77%. 4D Molecular Therapeutics (FDMT) +74%. Chenghe Acquisition Co (CHEA) +58%. Morphosys (MOR) +45%. Rail Vision Ltd (RVSN) +34%. Adverum Biotechnologies (ADVM) +...</p>\n\n<a href=\"https://seekingalpha.com/news/4062759-kpti-prso-and-nerv-among-mid-day-movers\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健护理机构","start_time":0,"source_url":"https://seekingalpha.com/news/4062759-kpti-prso-and-nerv-among-mid-day-movers","article_id":"2409455376","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2409455376","pubTimestamp":1707156353,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Gainers: Yield10 Bioscience  +77%. 4D Molecular Therapeutics  +74%. Chenghe Acquisition Co  +58%. Morphosys  +45%. Rail Vision Ltd  +34%. Adverum Biotechnologies  +32%. Karyopharm Therapeutics  +31%. ImmunoPrecise Antibodies Ltd  +26%. Datasea  +24%.  Minerva Neurosciences  +24%.  Losers: Cano Health  -49%,  Intelligent Bio Solutions  -38%. Bit Brother Limited  -29%. CCSC Technology International Holdings Limited  -28%. Scienjoy Holding Corporation  -26%. Peraso  -22%. Volcon  -23%. LuxUrban Hotels  -19%. Express  -18%.   More on Mid-day movers $ stocks.  Karyopharm: Approaching The Bottom Ahead Of Earnings And Topline Data  Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But Risky Peraso Inc.  Q3 2023 Earnings Call Transcript Karyopharm expects FY total revenue to be ~$145.9 million Peraso stock plummets on 1-for-40 reverse stock split","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","BK4082":"医疗保健设备","BK4563":"昨日强势股","BK4141":"半导体产品","KPTI":"Karyopharm Therapeutics Inc.","ADVM":"Adverum Biotechnologies, Inc.","MOR":"Morphosys AG","BK4157":"电子设备和仪器","EXPR":"Express, Inc.","BK4091":"摩托车制造商","INBS":"INTELLIGENT BIO SOLUTIONS INC","IPA":"Immunoprecise Antibodies Ltd","BK4097":"系统软件","BK4148":"电子元件","BK4121":"生命科学工具和服务","BK4113":"食品零售","LUXH":"LuxUrban Hotels","PRSO":"Peraso Inc","BK4094":"服装零售","CCTG":"CCSC Technology International Holdings Ltd.","VLCN":"Volcon Inc","YTEN":"Yield10 Bioscience, Inc.","BK4139":"生物科技","FDMT":"4D Molecular Therapeutics","SJ":"思享无限","BK4205":"房地产经营公司","BK4547":"WSB热门概念","NERV":"Minerva Neurosciences","RVSN":"Rail Vision Ltd","BK4233":"房地产运营公司","DTSS":"数海信息","BK4108":"电影和娱乐","BK4595":"比特币概念","BETS":"Bit Brother Limited"},"translate_title":"KPTI、PRSO和NERV在中午移动中","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KPTI":1,"CANO":1,"CCTG":1,"CHEA":1,"DTSS":1,"EXPR":1,"FDMT":1,"INBS":1,"IPA":1,"BETS":1,"LUXH":1,"MOR":1,"NERV":1,"PRSO":1,"RVSN":1,"SJ":1,"VLCN":1,"YTEN":1,"ADVM":1},"content_text":"Gainers: Yield10 Bioscience (YTEN) +77%. 4D Molecular Therapeutics (FDMT) +74%. Chenghe Acquisition Co (CHEA) +58%. Morphosys (MOR) +45%. Rail Vision Ltd (RVSN) +34%. Adverum Biotechnologies (ADVM) +32%. Karyopharm Therapeutics (KPTI) +31%. ImmunoPrecise Antibodies Ltd (IPA) +26%. Datasea (DTSS) +24%.  Minerva Neurosciences (NERV) +24%.  Losers: Cano Health (CANO) -49%,  Intelligent Bio Solutions (INBS) -38%. Bit Brother Limited (BETS) -29%. CCSC Technology International Holdings Limited (CCTG) -28%. Scienjoy Holding Corporation (SJ) -26%. Peraso (PRSO) -22%. Volcon (VLCN) -23%. LuxUrban Hotels (LUXH) -19%. Express (EXPR) -18%.   More on Mid-day movers $ stocks.  Karyopharm: Approaching The Bottom Ahead Of Earnings And Topline Data (Rating Upgrade) Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But Risky Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript Karyopharm expects FY total revenue to be ~$145.9 million Peraso stock plummets on 1-for-40 reverse stock split","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2409455376"}